Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,368 | 171 | 95.2% |
| Education | $220.49 | 4 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $867.36 | 30 | $0 (2024) |
| Novo Nordisk Inc | $752.54 | 24 | $0 (2024) |
| ABBVIE INC. | $537.48 | 24 | $0 (2024) |
| Lilly USA, LLC | $360.49 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $327.32 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $270.22 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $195.75 | 4 | $0 (2024) |
| Exact Sciences Corporation | $171.63 | 3 | $0 (2024) |
| PFIZER INC. | $153.10 | 10 | $0 (2024) |
| Dexcom, Inc. | $132.74 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,265 | 52 | AstraZeneca Pharmaceuticals LP ($347.04) |
| 2023 | $1,185 | 36 | Astellas Pharma US Inc ($291.32) |
| 2022 | $787.81 | 22 | Bayer HealthCare Pharmaceuticals Inc. ($230.22) |
| 2021 | $1,351 | 65 | Novo Nordisk Inc ($346.69) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: VACCINE | ||||||
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.28 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Biological | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.82 | General |
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $128.82 | General |
| Category: Oncology | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 08/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.61 | General |
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: VACCINE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $272.74 | $100.80 |
| 2022 | 7 | 504 | 611 | $103,552 | $29,298 |
| 2021 | 7 | 827 | 1,264 | $219,231 | $72,244 |
| 2020 | 8 | 879 | 1,269 | $147,014 | $61,461 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 13 | $272.74 | $100.80 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 289 | $54,728 | $12,356 | 22.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $14,725 | $10,100 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 123 | $21,634 | $3,533 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $5,756 | $1,761 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 17 | $2,691 | $1,027 | 38.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 14 | $1,050 | $288.43 | 27.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 24 | 35 | $1,605 | $167.20 | 10.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 16 | 16 | $1,363 | $65.22 | 4.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 277 | 586 | $111,194 | $31,967 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 190 | 190 | $29,450 | $20,364 | 69.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 261 | $47,270 | $8,896 | 18.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 60 | 60 | $15,699 | $4,979 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 46 | $7,280 | $2,919 | 40.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 22 | 27 | $3,618 | $2,468 | 68.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 57 | 82 | $3,720 | $389.39 | 10.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,000 | $260.81 | 26.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 252 | 445 | $53,877 | $21,438 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 190 | 190 | $28,815 | $18,027 | 62.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 234 | 376 | $36,457 | $10,797 | 29.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 43 | 53 | $6,947 | $4,375 | 63.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 39 | 39 | $10,036 | $3,290 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 25 | $3,893 | $1,316 | 33.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 12 | 12 | $2,896 | $1,264 | 43.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 61 | 103 | $2,535 | $550.48 | 21.7% |
About Michele Lively, APRN
Michele Lively, APRN is a Nurse Practitioner healthcare provider based in Georgetown, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437116241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Lively, APRN has received a total of $4,589 in payments from pharmaceutical and medical device companies, with $1,265 received in 2024. These payments were reported across 175 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,368).
As a Medicare-enrolled provider, Lively has provided services to 2,223 Medicare beneficiaries, totaling 3,157 services with total Medicare billing of $163,105. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Georgetown, SC
- Active Since 04/26/2006
- Last Updated 12/03/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1437116241
Products in Payments
- FARXIGA (Drug) $568.68
- Kerendia (Drug) $270.22
- RYBELSUS (Drug) $254.78
- UBRELVY (Drug) $236.95
- VRAYLAR (Drug) $231.57
- REXULTI (Drug) $195.75
- MOUNJARO (Drug) $176.29
- Ozempic (Drug) $171.96
- Cologuard Collection Kit (Device) $171.63
- Veozah (Drug) $143.44
- Rybelsus (Drug) $141.43
- Dexcom G6 Transmitter (Medical Supply) $132.74
- BREZTRI (Drug) $130.88
- SUNOSI (Drug) $122.60
- AIRSUPRA (Drug) $98.66
- JARDIANCE (Drug) $98.63
- LifeVest (Device) $98.11
- YUPELRI (Drug) $89.00
- TRELEGY ELLIPTA (Drug) $76.30
- ELIQUIS (Drug) $71.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Georgetown
Tricia Greer
Nurse Practitioner — Payments: $10,748
Morgan Riley, Aprn, APRN
Nurse Practitioner — Payments: $4,409
Logan Ford
Nurse Practitioner — Payments: $3,159
Leena Saj, Crnp, CRNP
Nurse Practitioner — Payments: $2,518
Mrs. Amy Smith, Aprn, APRN
Nurse Practitioner — Payments: $2,483
Melissa Galloway
Nurse Practitioner — Payments: $2,229